MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

MPR Drug News

Case: Inhaled Corticosteroid-Induced Myopathy in HIV Patient

Initially, the team attributed the muscle weakness to either HIV or drug-mediated myopathy but a muscle biopsy later revealed atrophy of type II fibers without necrosis or inflammation.

First ESA Biosimilar Gets FDA Advisory Committee Nod

The FDA will consider the Committee's recommendation before acting on the biologics license application (BLA) for the epoetin alfa biosimilar.

Statin Benefits Go Beyond Lowering Cholesterol, Study Finds

Multiple regression analysis showed that those taking statins had a 2.4% lower left ventricular mass and lower left and right ventricular volumes.

Cannabidiol Oral Solution Studied in Drug-Resistant Seizures

The data showed a reduction in the median frequency of convulsive seizure per month from 12.4 to 5.9 with cannabidiol vs. a reduction from 14.9 to 14.1 with placebo.

Recall: CV Meds Found to Contain Gout Pills

Accidental patient dosing with Zurampic can potentially cause adverse renal effects such as acute renal failure; this is more common if Zurampic is given alone without a xanthine oxidase inhibitor.